MANAGING THE INR CLINIC : IJN EXPERIENCE

Size: px
Start display at page:

Download "MANAGING THE INR CLINIC : IJN EXPERIENCE"

Transcription

1 MANAGING THE INR CLINIC : IJN EXPERIENCE Anticoagulation Workshop 21 st August 2015 KAMALESWARY ARUMUGAM PRINCIPAL PHARMACIST LEE LEE HO1 NURSE MENTOR, INR CLINIC

2 HISTORY & OVERVIEW OF THE INR CLINIC

3 HISTORY Established in July 2003 by Dr. Lam Kai Huat It is for better management of warfarin therapy by a team of health professionals fully trained in anticoagulation management Laboratory dept priority was given to warfarin patients and the old blood bank location was used as the INR clinic Pharmacy dept pharmacists guided staff nurses in educating warfarin patients as well as provide warfarin dose adjustments & dispensing warfarin from the clinic Emergency dept Patients with out of range INR referred to M.O. Since then: our INR clinic has further expanded to 3 permanent clinic rooms and the patients numbers have increased steadily over the last 10 years Dispensing of Warfarin has been centralised Pharmacy Outpatient Block B

4 HISTORY Protocol and policy has been developed to standardise anticoagulant management Staff nurses and pharmacists were sent to Singapore GH to attend Anticoagulation workshop 2005 onwards Pharmacy/INR Clinic collaborate with IJN College to organise the first Oral Anticoagulation workshop in August 2010 In 2014, we started training our own nurses and pharmacists and a second Anticoagulation workshop was successfully conducted in September 2014

5

6 INR CLINIC ORGANISATION CHART

7 INR CLINIC LOCATION & OPERATING HOURS The INR clinic is located on Ground Floor, Block B, IJN The clinic is operated based on normal working hours 8:00am to 5:00pm, 5 days a week (Monday to Friday), excluding public holiday During the lunch hour (Monday to Thursday 1:00pm-2:00 pm; Friday 12:30pm-2:30pm), the clinic is closed

8 OBJECTIVES To assist physicians in the management of patients on oral anticoagulation therapy To provide service continuity and enhance patient care through education, monitoring and close follow-up to patients who require anticoagulation therapy To serve as an information resource regarding warfarin for patients and family/care provider To conduct research regarding anticoagulation therapy and related areas

9 SCOPE All IJN Out-patients who are scheduled for INR test in IJN All IJN POCT patients Patients newly started on warfarin therapy in the ward, physicians shall refer patient to the INR clinic upon discharge Physicians will have to document the patient s indication for anticoagulation, intended duration of anticoagulation, and targeted INR in the patient warfarin record book upon referral

10 INR CLINIC WORKFLOW

11 MANPOWER REQUIREMENT The INR clinic is staffed by full time nurses 5 days a week: From : 2 staff nurses From March 2014 onwards: 3 staff nurses A pharmacist is on-site from 8:00am to 1:00pm (Monday to Thursday) and 8:00am to 12.30pm (Friday) to provide support for the anticoagulation services in dose adjustments and general management of the clinic The physician provides support of the clinical services and medical authority in management of the clinic services

12 MANPOWER REQUIREMENT

13 ROLES & RESPONSIBILITIES OF THE INR CLINIC NURSES & PHARMACISTS Conduct interview using INR Clinic Patient Assessment Form Evaluate patient s response to warfarin therapy through the INR results and information gathered from patient s interview Adjust dose according to patient specific response (INR trend, compliance issues and outcomes from initial assessment interview) Complete documentation in warfarin record book, patient assessment form Schedule appointments

14 PATIENT ASSESSMENT FORM

15 SPECIFIC ROLES & RESPONSIBILITIES OF THE INR CLINIC NURSES At the end of the day transfer information into INR clinic database in Trakcare Ensure Prescriptions Slips are collected for endorsement by physician at the end of the day Administer Vitamin K & SC Anticoagulant to patients, if indicated Teach patients to self-administer SC Anticoagulant Arrange for patient admission, if indicated

16 PROTOCOL

17 DOSE ADJUSTMENTS Dosage adjustment and duration of recall are generally done referring to Appendix 4

18

19 DOSE ADJUSTMENTS Dosage adjustment and duration of recall are generally done referring to Appendix 4 The pharmacist or nurse is authorised to adjust warfarin dosage using a doctor s standing instruction on the Prescription Slip The prescription will be counter-signed by the appointed physician later on

20 DOSE ADJUSTMENTS In general, the pharmacist or nurse manage all patients with INR of 1.4 to 5.0 If INR <1.4 refer to physician (unless AVR & MVR) If INR >4.0: check for any sign and symptoms of bleeding and determine any cause or triggers for the increase in INR where there s unexplained increase in the INR, the patient management & therapy is discussed with a physician if deemed appropriate, patient s INR of 5.0 & there is a significant factor attributing to the increase in INR, the pharmacist or nurse can manage the patient anticoagulation therapy provided that there is no actual or suspected signs or symptoms of bleeding

21 REFERRAL TO PHYSICIAN The patient are referred to a physician in the following situation: Actual or suspected signs and symptoms of severe haemorrhage regardless of INR value Actual or suspected signs and symptoms of thromboembolism INR values >5.0, with or without signs and symptoms of haemorrhage Patients with prosthetic valve replacement: mechanical aortic valve with INR 1.6 or mechanical mitral valve with INR 1.7 When Anticoagulation patient consistently Symposium & Workshop miss appointments 2015 or remain non-compliant to therapy

22

23

24

25

26 POCT

27 HOME MONITORING In 2006, Dr. Lam took a step forward, introducing the patient selfmanagement of INR (POCT Point of Care Test) Patients perform POCT at home and contact the INR clinic for warfarin dosage adjustment The home monitoring program for patients is ongoing low numbers currently Advantages: Convenience time & cost saved from travelling to hospital Compliance to treatment is better Improved quality of life

28 STAFF COMPETENCY

29 COMPETENCY ASSESSMENT Formally started in 2015 All nurses & pharmacists working in the INR Clinic must undergo competency assessment Yearly assessment 3 components: Peer review Case presentation Written assessment Must pass all 3 components

30 PEER REVIEW

31 PEER REVIEW

32 PEER REVIEW Assessed on 8 elements: Introduction to consultation Patient interview Review of INR result & action taken INR monitoring Provision of information for ongoing care Knowledge application Communication skills Documentation of clinic activities

33 COMPETENCY ASSESSMENT Case presentation: 2 subtherapeutic & 2 supratherapeutic cases & management Presented to Pharmacists & Nurses who work in the INR clinic, students & interns Written assessment knowledge based Must have attended Anticoagulation Workshop/Training

34 STATISTICS

35 PATIENT VISITS 11 YEARS DATA INR CLINIC PATIENT VISITS - 11 YEARS DATA NO OF PATIENT VISITS YEAR

36 INR CLINIC VISITS BY INDICATION (YEAR 2014) Other indications, 2339, 11% PE/DVT, 426, 2% Valve Repair, 492, 2% AF, 6513, 32% Valve Replacement, 10819, 53%

37 TTR Time in therapeutic range = TTR Percentage of time when patient has an INR in the prescribed range when stroke & bleeding risk is lowest Good TTR is INR in the range 2-3 >70% of the time Calculation is done based on Traditional method Ref: data/assets/pdf_file/0004/222277/medicinewise-news-feb-2012-managing-inr-figure.pdf

38 INR RESULTS FOR TARGET RANGE (YEAR 2014) , 984, 9% above 5, 97, 1% below 1.8, 2011, 18% , 7818, 72%

39 FUTURE PLANS

40 ANTICOAGULATION SOFTWARE Many available on the market Designed to help establish a more efficient, effective and safer way of managing patients Complete anticoagulation decision support package covering induction, maintenance, bridging, novel oral anticoagulants and VTE diagnosis assessment

41 ANTICOAGULATION SOFTWARE PRODUCT SPECIFICATIONS/FUNCTIONS Generate letters/reports for internal/external physicians caring for patient Increase efficiency Reduce repetitive tasks Monitor patients who missed appointments Reduce potential errors in transcribing Able to track patient load/day Countercheck dose & dosing interval Objectives Easy data retrieval for future research Alert any drug interactions Benchmark clinic against other organisatons for further improvement Highlight high risk patients for further management Individual TTR report for better management Report yearly patient visits & patient numbers Overall clinic TTR reporting

42 WITHOUT ANTICOAGULATION SOFTWARE Generate letters/reports Manual for external process physicians caring for patient Increase efficiency Reduce repetitive tasks Monitor patients who missed appointments Reduce potential errors in transcribing Manual Able to track patient process load/day Countercheck dose & dosing interval Objectives Manual Easy data retrieval for future process research Alert any drug interactions Benchmark clinic against other organisatons for further improvement Highlight high risk patients for further management Individual TTR report for better management Report yearly patient Manual visits & patient process numbers Manual process Overall clinic TTR reporting

43 ANTICOAGULATION SOFTWARE BENEFITS Generate letters/reports for internal/external physicians caring for patient Increase efficiency Reduce repetitive tasks Monitor patients who missed appointments Reduce potential errors in transcribing Able to track patient load/day Countercheck dose & dosing interval Objectives Easy data retrieval for future research Alert any drug interactions Benchmark clinic against other organisatons for further improvement Highlight high risk patients for further management Improve patient safety Individual TTR report for better management Report yearly patient visits & patient numbers Overall clinic TTR reporting

44 ANTICOAGULATION SOFTWARE BENEFITS Generate letters/reports for internal/external physicians caring for patient Increase efficiency Reduce repetitive tasks Monitor patients who missed appointments Reduce potential errors in transcribing Able to track patient load/day Countercheck dose & dosing interval Increase efficiency Objectives Easy data retrieval for future research Alert any drug interactions Benchmark clinic against other organisatons for further improvement Highlight high risk patients for further management Individual TTR report for better management Report yearly patient visits & patient numbers Overall clinic TTR reporting

45 ANTICOAGULATION SOFTWARE BENEFITS Generate letters/reports for internal/external physicians caring for patient Increase efficiency Reduce repetitive tasks Monitor patients who missed appointments Reduce potential errors in transcribing Improvement on all processes Able to track patient load/day Objectives Countercheck dose & dosing interval Easy data retrieval for future research Alert any drug interactions Benchmark clinic against other organisatons for further improvement Highlight high risk patients for further management Individual TTR report for better management Report yearly patient visits & patient numbers Overall clinic TTR reporting

46 PATIENT PROFILE

47 RISK STRATIFICATION & TTR INDICATOR

48 DRUG INTERACTIONS & EVENTS

49 DOSE SETTING CLEAR

50 SUMMARY INR Clinic is successfully managed by MDT In the last 11 years patient numbers have increased significantly Process improvements have been made in the clinic Future plans include implementation of an anticoagulation software to increase patient safety & efficiency

51 THANK YOU

ANTI-COAGULATION MONITORING

ANTI-COAGULATION MONITORING ANTI-COAGULATION MONITORING 2016-17 a) Purpose of Agreement This Agreement outlines the service to be provided by the Provider, called an Anti-coagulation monitoring service. b) Duration of Agreement This

More information

Anti-Coagulation Monitoring (warfarin, acenocoumarol, phenindione) Primary Care Service (PCS:01) NHS Standard Contract Service Profile Pack ( )

Anti-Coagulation Monitoring (warfarin, acenocoumarol, phenindione) Primary Care Service (PCS:01) NHS Standard Contract Service Profile Pack ( ) Anti-Coagulation Monitoring (warfarin, acenocoumarol, phenindione) Primary Care Service (PCS:01) This pack contains: Standard Contract Service Profile Pack () 1. Service Specification: (to be inserted

More information

CLINICAL AUDIT. The Safe and Effective Use of Warfarin

CLINICAL AUDIT. The Safe and Effective Use of Warfarin CLINICAL AUDIT The Safe and Effective Use of Warfarin Valid to May 2019 bpac nz better medicin e Background Warfarin is the medicine most frequently associated with adverse drug reactions in New Zealand.

More information

An Evaluation of the BVH Initiation of warfarin for DVT. Sean O Brien Specialist Anticoagulation BMS Oct 2015

An Evaluation of the BVH Initiation of warfarin for DVT. Sean O Brien Specialist Anticoagulation BMS Oct 2015 An Evaluation of the BVH Initiation of warfarin for DVT Sean O Brien Specialist Anticoagulation BMS Oct 2015 Service Provision ADAS is a Consultant led service managed by the Pathology Directorate. Provides

More information

Indian River Medical Center Policy #: 10.1 Policies and Procedures

Indian River Medical Center Policy #: 10.1 Policies and Procedures Indian River Medical Center Policy #: 10.1 Policies and Procedures Title: ANTICOAGULATION CLINIC Effective Date: Chapter: Pharmacy Reviewed Date: Responsible Person: Director of Pharmacy Revised Date:

More information

Reducing Medication Errors: National Update

Reducing Medication Errors: National Update Reducing Medication Errors: National Update Ahmed Ameer Medication Safety Officer Ahmed.Ameer@NHS.net Safer Medication Practice & Medical Devices Team 27 th January 2015 Agenda 1. Development of the National

More information

War on Warfarin: Integrating DOACs into your Anticoagulation Service

War on Warfarin: Integrating DOACs into your Anticoagulation Service War on Warfarin: Integrating DOACs into your Anticoagulation Service David DeiCicchi, Pharm.D, CACP Brigham and Women s Hospital September 30 th, 2016 Disclosures I have no financial conflict of interest

More information

Reducing Warfarin ADR s with a Nurse Led Anticoagulation Clinic: A New Model of Patient Care

Reducing Warfarin ADR s with a Nurse Led Anticoagulation Clinic: A New Model of Patient Care Baptist Health South Florida Scholarly Commons @ Baptist Health South Florida All Publications 6-16-2017 Reducing Warfarin ADR s with a Nurse Led Anticoagulation Clinic: A New Model of Patient Care Michael

More information

Adverse Drug Events: A Focus on Anticoagulation Steve Meisel, Pharm.D., CPPS Director of Patient Safety Fairview Health Services, Minneapolis, MN

Adverse Drug Events: A Focus on Anticoagulation Steve Meisel, Pharm.D., CPPS Director of Patient Safety Fairview Health Services, Minneapolis, MN Adverse Drug Events: A Focus on Anticoagulation Steve Meisel, Pharm.D., CPPS Director of Patient Safety Fairview Health Services, Minneapolis, MN Fairview Health Services 6 hospitals, ranging from rural

More information

Clinical. Prescribing Medicines SOP. Document Control Summary. Contents

Clinical. Prescribing Medicines SOP. Document Control Summary. Contents Clinical Prescribing Medicines SOP Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation Date: Review Date: Key

More information

Camden Clinical Commissioning Group Reporting Mechanism/Frequency Remotely/Quarterly

Camden Clinical Commissioning Group Reporting Mechanism/Frequency Remotely/Quarterly Universal Offer Service Anticoagulation - Warfarin Clinical Lead Dr Kevan Ritchie Commissioner Camden Clinical Commissioning Group Reporting Mechanism/Frequency Remotely/Quarterly Payment Frequency Quarterly

More information

Anticoagulation Manager Training Day Plan

Anticoagulation Manager Training Day Plan Anticoagulation Manager Training Day Plan Versioning Author: Debbie Cuthbert/Emma Stubbs Reviewer(s): Debbie Cuthbert, Jim Holden Date Version Contents 22/10/2014 01 Initial draft day plan. 31/10/2014

More information

Improving Safety Practices Anticoagulation Therapy

Improving Safety Practices Anticoagulation Therapy Improving Safety Practices Anticoagulation Therapy Katie Cinnamon, PharmD, BCPS Clinical Pharmacist Genesis Medical Center - Davenport Objectives Review background information on medication errors and

More information

Alert. Patient safety alert. Actions that can make anticoagulant therapy safer. 28 March Action for the NHS and the independent sector

Alert. Patient safety alert. Actions that can make anticoagulant therapy safer. 28 March Action for the NHS and the independent sector Patient safety alert 18 Alert 28 March 2007 Immediate action Action Update Information request Ref: NPSA/2007/18 Actions that can make anticoagulant therapy safer Anticoagulants are one of the classes

More information

This controlled document shall not be copied in part or whole without the express permission of the author or the author s representative.

This controlled document shall not be copied in part or whole without the express permission of the author or the author s representative. This document is also available in large print and other formats and languages, upon request. Please call NHS Grampian Corporate Communications on (01224) 551116 or (01224) 552245. This controlled document

More information

Oxfordshire Anticoagulation Service. Important information about anticoagulation with vitamin K antagonists Information for patients

Oxfordshire Anticoagulation Service. Important information about anticoagulation with vitamin K antagonists Information for patients Oxfordshire Anticoagulation Service Important information about anticoagulation with vitamin K antagonists Information for patients Page 2 Your information Name:... Address:......... or patient stickie

More information

Storyboard Submission NHS Wales Awards Title Improving Patient Safety How ABHB Ward Pharmacists Monitor Elevated INRs

Storyboard Submission NHS Wales Awards Title Improving Patient Safety How ABHB Ward Pharmacists Monitor Elevated INRs Storyboard Submission 1. Title Improving Patient Safety How ABHB Ward Pharmacists Monitor Elevated 2. Brief Outline of Context As part of the 1000 Lives Plus initiative, ward pharmacists throughout ABHB

More information

Comparison of a clinical pharmacist managed anticoagulation service with routine medical care: impact on clinical outcomes and health care costs

Comparison of a clinical pharmacist managed anticoagulation service with routine medical care: impact on clinical outcomes and health care costs HEALTH SERVICES RESEARCH FUND HEALTH CARE AND PROMOTION FUND Comparison of a clinical pharmacist managed anticoagulation service with routine medical care: impact on clinical outcomes and health care costs

More information

Pharmaceutical Services Report to Joint Conference Committee September 2010

Pharmaceutical Services Report to Joint Conference Committee September 2010 Pharmaceutical Services Report to Joint Conference Committee September 21 Background: Pharmaceutical Services staffing has increased by 31 FTE from 26 due to program changes and to comply with regulatory

More information

STANDING ORDERS FOR THE MANAGEMENT OF WARFARIN Dose adjustment and INR testing frequency Applicable to: Pharmacists. Issued by: Contact:

STANDING ORDERS FOR THE MANAGEMENT OF WARFARIN Dose adjustment and INR testing frequency Applicable to: Pharmacists. Issued by: Contact: STANDING ORDERS FOR THE MANAGEMENT OF WARFARIN Dose adjustment and INR testing frequency Applicable to: Pharmacists Standing Order used for the Community Pharmacy Anticoagulant Management (CPAM) Service

More information

Harrison Memorial Hospital Cynthiana, KY. Rachel Harney, PharmD Director of Pharmacy ADEs Related to Coumadin March 1, 2018

Harrison Memorial Hospital Cynthiana, KY. Rachel Harney, PharmD Director of Pharmacy ADEs Related to Coumadin March 1, 2018 Harrison Memorial Hospital Cynthiana, KY Rachel Harney, PharmD Director of Pharmacy ADEs Related to Coumadin March 1, 2018 About Us HMH is a regional healthcare facility licensed to operate 61 beds 20

More information

Initiation of Warfarin for patients not registered with Provider Practice

Initiation of Warfarin for patients not registered with Provider Practice Initiation of Warfarin for patients not registered with Provider Practice 2017-18 1. Purpose of Agreement This Agreement outlines the service to be provided by the Provider, called Initiation of Warfarin

More information

Linda Cutter / Dr Charles Heatley. GP Practices and Community Pharmacies

Linda Cutter / Dr Charles Heatley. GP Practices and Community Pharmacies Schedule 2 Part A Service Specification Service Specification No. 04 Service Anti-coagulation Monitoring Levels 3, 4 & 5 Commissioner Lead Provider Lead Linda Cutter / Dr Charles Heatley GP Practices and

More information

Setting up the NOAC Service & Taking it to Primary Care

Setting up the NOAC Service & Taking it to Primary Care Setting up the NOAC Service & Taking it to Primary Care Satinder Bhandal Consultant Anticoagulation Pharmacist November 2015 Buckinghamshire Health Care NHS Trust Quiz 1. What is the most serious side

More information

Inpatient Anticoagulation Management Services to Improve Transitions of Care

Inpatient Anticoagulation Management Services to Improve Transitions of Care Inpatient Anticoagulation Management Services to Improve Transitions of Care Andrea Resseguie PharmD, RPh, CACP Advanced Practice Clinical Specialist Anticoagulation Management Service Learning Objectives

More information

Sheffield Teaching Hospitals: Pulmonary Hypertension. Information for Medical Staff 31/03/2014. Local guidelines

Sheffield Teaching Hospitals: Pulmonary Hypertension. Information for Medical Staff 31/03/2014. Local guidelines Sheffield Teaching Hospitals: Pulmonary Hypertension Information for Medical Staff 31/03/2014 Local guidelines Diagnostic pathway - page 2 Iloprost dosing chart and conversion table - page 3-4 Hickman

More information

Patient Weighing Scales Policy

Patient Weighing Scales Policy Patient Weighing Scales Policy Policy Title: Executive Summary: Patient Weighing Scales Policy East Cheshire NHS Trust is committed to the health safety and welfare of all of the patients it treats. The

More information

Diploma In Drug & Pharmacy CURRICULUM/SYLLABUS. Course Code: 8274

Diploma In Drug & Pharmacy CURRICULUM/SYLLABUS. Course Code: 8274 Diploma In Drug & Pharmacy CURRICULUM/SYLLABUS Course Code: 8274 This program is aimed at training candidates for the job of a Working in Medical Stores or in Pharmacy Company where he/she can able to

More information

Anticoagulation: Safe prescribing, dispensing and administration of oral and parenteral anticoagulants

Anticoagulation: Safe prescribing, dispensing and administration of oral and parenteral anticoagulants Trust Policy Anticoagulation: Safe prescribing, dispensing and administration of oral and parenteral anticoagulants Purpose Date Version March 2015 2 To manage the inherent risks to patients from the use

More information

ANTICOAGULATION MONITORING SERVICE. Standard Operating Procedure For the provision of a Level 3, 4 and 5 Anticoagulation Service

ANTICOAGULATION MONITORING SERVICE. Standard Operating Procedure For the provision of a Level 3, 4 and 5 Anticoagulation Service ANTICOAGULATION MONITORING SERVICE Standard Operating Procedure For the provision of a Level 3, 4 and 5 Anticoagulation Service Version: Date at ET/PEC: September 2008 Date ratified at Board: Name and

More information

Medication Adherence

Medication Adherence Medication Adherence Robert DiGregorio, PharmD, FNAP, BCACP Professor (Long Island University) Sr. Director, Pharmacy & Pharmacotherapy Services (TBHC) Chief, Pharmacotherapy Department of Internal Medicine

More information

Comparison of Anticoagulation Clinic Patient Outcomes With Outcomes From Traditional Care in a Family Medicine Clinic

Comparison of Anticoagulation Clinic Patient Outcomes With Outcomes From Traditional Care in a Family Medicine Clinic Comparison of Anticoagulation Clinic Patient Outcomes With Outcomes From Traditional Care in a Family Medicine Clinic Marvin A. Chamberlain, RPh, MS, Nannette A. Sageser, Pharm D, and David Ruiz, MD Background:

More information

HIQA s Medication Safety Monitoring Programme in Public Acute Hospitals. One Year Later

HIQA s Medication Safety Monitoring Programme in Public Acute Hospitals. One Year Later HIQA s Medication Safety Monitoring Programme in Public Acute Hospitals One Year Later Sean Egan Head of Healthcare Regulation Health Information and Quality Authority Presentation outline Recap on the

More information

4/9/2013. Best Practice Initiative: Inpatient Anticoagulation Stewardship. Dorcas Letting reports no relevant financial relationships

4/9/2013. Best Practice Initiative: Inpatient Anticoagulation Stewardship. Dorcas Letting reports no relevant financial relationships Disclosure Best Practice Initiative: Inpatient Anticoagulation Stewardship Dorcas Letting reports no relevant financial relationships Dorcas Letting-Mangira, Pharm.D Pharmacotherapist, Internal Medicine

More information

Document ref. no: Trust Policy and Procedure PP(16)238 MANAGEMENT OF ADULT PATIENTS TREATED WITH ORAL ANTICOAGULANTS. Approved

Document ref. no: Trust Policy and Procedure PP(16)238 MANAGEMENT OF ADULT PATIENTS TREATED WITH ORAL ANTICOAGULANTS. Approved Document ref. no: Trust Policy and Procedure PP(16)238 MANAGEMENT OF ADULT PATIENTS TREATED WITH ORAL ANTICOAGULANTS For use in: For use by: For use for: Document owner: Status: West Suffolk NHS Foundation

More information

Community DVT Service. Phase 3: Anticoagulation at DVT Treatment Centres

Community DVT Service. Phase 3: Anticoagulation at DVT Treatment Centres Community DVT Service Quick Reference Guide Phase - Anticoagulation Phase : Anticoagulation at DVT Treatment Centres If a Patient has had a positive Ultrasound Scan they attend one of the DVT Treatment

More information

Overview and History of AMS. Lynn Oertel, MS, ANP, CACP Clinical Nurse Specialist Anticoagulation Management Service MESAC - November 18, 2014

Overview and History of AMS. Lynn Oertel, MS, ANP, CACP Clinical Nurse Specialist Anticoagulation Management Service MESAC - November 18, 2014 Overview and History of AMS Lynn Oertel, MS, ANP, CACP Clinical Nurse Specialist Anticoagulation Management Service MESAC - November 18, 2014 Anticoagulation Management Service (AMS) Location POB, 275

More information

Improvement Activities for ACI Bonus Measures

Improvement Activities for ACI Bonus Measures Improvement Activity Performance Category Subcategory Expanded Practice Activity Name Activity Improvement Activity Performance Category Weight Provide 24/7 access to eligible clinicians or groups, who

More information

Advancing Care Information Performance Category Fact Sheet

Advancing Care Information Performance Category Fact Sheet Fact Sheet The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) replaced three quality programs (the Medicare Electronic Health Record (EHR) Incentive program, the Physician Quality Reporting

More information

Drug Therapy Management

Drug Therapy Management 4/17 Welcome to the Centers of Excellence Assessment Becoming an Anticoagulation Center of Excellence gives your service the chance to work as a multidisciplinary team to evaluate your current safety practices

More information

Improving compliance with oral methotrexate guidelines. Action for the NHS

Improving compliance with oral methotrexate guidelines. Action for the NHS Patient safety alert 13 Alert Immediate action Action Update Information request Ref: NPSA/2006/13 Improving compliance with oral methotrexate guidelines Oral methotrexate is a safe and effective medication

More information

Pharmacological Therapy Practice Guidance Note Medicine Reconciliation on Admission to Hospital for Adults in all Clinical Areas within NTW V02

Pharmacological Therapy Practice Guidance Note Medicine Reconciliation on Admission to Hospital for Adults in all Clinical Areas within NTW V02 Pharmacological Therapy Practice Guidance Note Medicine Reconciliation on Admission to Hospital for Adults in all Clinical Areas within NTW V02 V02 issued Issue 1 May 11 Issue 2 Dec 11 Planned review May

More information

SCHEDULE 2 THE SERVICES

SCHEDULE 2 THE SERVICES SCHEDULE 2 THE SERVICES A. Service Specifications 1 Introduction Anticoagulants are medicines which slow down the blood clotting process and are used to support the prevention of clot development. They

More information

Promoting Interoperability Performance Category Fact Sheet

Promoting Interoperability Performance Category Fact Sheet Promoting Interoperability Fact Sheet Health Services Advisory Group (HSAG) provides this eight-page fact sheet to help providers with understanding Activities that are eligible for the Promoting Interoperability

More information

Introduction of Clinical Nurse Specialists to the Leeds Anticoagulation Service- Changing Perceptions

Introduction of Clinical Nurse Specialists to the Leeds Anticoagulation Service- Changing Perceptions Introduction of Clinical Nurse Specialists to the Leeds Anticoagulation Service- Changing Perceptions Karen Hodgkinson RN, BSc (Hons) Clinical Nurse Specialist/ Team Leader DAWN USER GROUP- Monday 3rd

More information

Commissioning effective anticoagulation services for the future: A resource pack for commissioners

Commissioning effective anticoagulation services for the future: A resource pack for commissioners Commissioning effective anticoagulation services for the future: A resource pack for commissioners The development of this commissioning toolkit was supported by Bayer HealthCare. Bayer HealthCare paid

More information

ATRIAL FIBRILLATION & STROKE INSIGHTS TOOL

ATRIAL FIBRILLATION & STROKE INSIGHTS TOOL ATRIAL FIBRILLATION & STROKE INSIGHTS TOOL CAN REAL WORLD/PUBLICALLY AVAILABLE DATA COUPLED WITH TTR DATA HELP THE NHS STOP STROKES? Andrzei Orlowski -Programme Development Lead for Health and Implementation

More information

Transnational Skill Standards Pharmacy Assistant

Transnational Skill Standards Pharmacy Assistant Transnational Skill Standards Pharmacy Assistant REFERENCE ID: HSS/ Q 5401 Mapping for Pharmacy Assistant (HSS/ Q 5401) with UK SVQ level 2 Qualification Certificate in Pharmacy Service Skills Link to

More information

Protocol for Patients on oral Anticoagulants who wish to perform INR self testing. Anticoagulation service Bolton NHS Foundation Trust. April 2017.

Protocol for Patients on oral Anticoagulants who wish to perform INR self testing. Anticoagulation service Bolton NHS Foundation Trust. April 2017. Protocol for Patients on oral Anticoagulants who Anticoagulation service Bolton NHS Foundation Trust April 2017. Document Control Document Ref No. ANTICO05 Title of document Protocol for Patient s on oral

More information

Digital INR Monitoring A model of remote INR testing. Ian Dove, Tracy Murphy, Jeannie Hardy County Durham and Darlington NHS FT

Digital INR Monitoring A model of remote INR testing. Ian Dove, Tracy Murphy, Jeannie Hardy County Durham and Darlington NHS FT Digital INR Monitoring A model of remote INR testing Ian Dove, Tracy Murphy, Jeannie Hardy County Durham and Darlington NHS FT About NHS Health Call NHS Health Call is a digital health partnership between

More information

Disease State Management Clinics: A Pharmacist Perspective

Disease State Management Clinics: A Pharmacist Perspective Disease State Management Clinics: A Pharmacist Perspective Eva Berrios Colon, Pharm.D, MPH, BCPS Associate Professor, Touro College of Pharmacy Email: evb9001@nyp.org 5/12/11 The Brooklyn Hospital Center

More information

NEW JERSEY. Downloaded January 2011

NEW JERSEY. Downloaded January 2011 NEW JERSEY Downloaded January 2011 SUBCHAPTER 29. MANDATORY PHARMACY 8:39 29.1 Mandatory pharmacy organization (a) A facility shall have a consultant pharmacist and either a provider pharmacist or, if

More information

Safer use of anticoagulants: the NPSA patient safety alert Steve Chaplin MSc, MRPharmS

Safer use of anticoagulants: the NPSA patient safety alert Steve Chaplin MSc, MRPharmS Safer use of anticoagulants: the NPSA patient safety alert Steve Chaplin MSc, MRPharmS Steve Chaplin describes the NPSA s anticoagulant patient safety alert and the measures it recommends for making the

More information

Advancing Care Information Measures

Advancing Care Information Measures Participants: Advancing Care Information Measures In 2017, Advancing Care Information (ACI) measure reporting is optional for Nurse Practitioners, Physician Assistants, Clinical Nurse Specialists, CRNAs,

More information

ARTICLE. The community pharmacybased anticoagulation management service achieves a consistently high standard of anticoagulant care

ARTICLE. The community pharmacybased anticoagulation management service achieves a consistently high standard of anticoagulant care The community pharmacybased anticoagulation management service achieves a consistently high standard of anticoagulant care Paul Harper, Ian McMichael, Dale Griffiths, Joe Harper, Claire Hill ABSTRACT AIM:

More information

NPSA Alert 03: Reducing the harm caused by oral Methotrexate. Implementation Progress Report July Learning and Sharing

NPSA Alert 03: Reducing the harm caused by oral Methotrexate. Implementation Progress Report July Learning and Sharing NPSA Alert 03: Reducing the harm caused by oral Methotrexate Implementation Progress Report July 2006 Learning and Sharing CONTENTS Page 1 Background 3 2 Findings 4 Appendix 1 Summary of responses 6 Appendix

More information

Literature review: pharmaceutical services for prisoners

Literature review: pharmaceutical services for prisoners Author: Rosemary Allgeier, Principal Pharmacist in Public Health. Date: 08 October 2012 Version: 1a Publication and distribution: NHS Wales (intranet and internet) Public Health Wales (intranet and internet)

More information

In-Patient Medication Order Entry System - contribution of pharmacy informatics

In-Patient Medication Order Entry System - contribution of pharmacy informatics In-Patient Medication Order Entry System - contribution of pharmacy informatics Ms S C Chiang BPharm, MRPS, MHA, FACHSE, FHKCHSE, FCPP Senior Pharmacist Chief Pharmacist s Office In-Patient Medication

More information

Promoting Interoperability Measures

Promoting Interoperability Measures Promoting Interoperability Measures Previously known as Advancing Care Information for 2017 and Meaningful Use from 2011-2016 Participants: In 2018, promoting interoperability measure reporting (PI) is

More information

Service Specification

Service Specification Service Specification Level 4 Anticoagulation Management Release: Final Date: 1/1/11 Author: Suzanne Pickering Primary Care Commissioning Manager NHS Derbyshire County Owner: Jackie Pendleton Assistant

More information

Medicines Reconciliation: Standard Operating Procedure

Medicines Reconciliation: Standard Operating Procedure Clinical Medicines Reconciliation: Standard Operating Procedure Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation

More information

Research Article A Pharmacist-Led Point-of-Care INR Clinic: Optimizing Care in a Family Health Team Setting

Research Article A Pharmacist-Led Point-of-Care INR Clinic: Optimizing Care in a Family Health Team Setting International Family Medicine, Article ID 691454, 4 pages http://dx.doi.org/10.1155/2013/691454 Research Article A Pharmacist-Led Point-of-Care INR Clinic: Optimizing Care in a Family Health Team Setting

More information

Introduction. Singapore and its Quality and Patient Safety Position. Singapore 2004: Top 5 Key Risk Factors. High Body Mass

Introduction. Singapore and its Quality and Patient Safety Position. Singapore 2004: Top 5 Key Risk Factors. High Body Mass Introduction Singapore and its Quality and Patient Safety Position Singapore 2004: Top 5 Key Risk Factors High Body Mass (11.1%; 45,000) Physical Inactivity (3.8%; 15,000) Cigarette Smoking (7.4%; 28,000)

More information

Protocol Applies To: UW Health Clinics: all adult outpatients with an active order for warfarin

Protocol Applies To: UW Health Clinics: all adult outpatients with an active order for warfarin Protocol Number: 7 Protocol Title: Ambulatory Initiation and Management of Warfarin for Adults Protocol Applies To: UW Health Clinics: all adult outpatients with an active order for warfarin Target Patient

More information

Policy for Venous Thromboembolism Prevention and Treatment

Policy for Venous Thromboembolism Prevention and Treatment Policy for Venous Thromboembolism Prevention and Treatment Start date: May 2013 Next Review: May 2015 Committee approval: Endorsed by: Distribution: Location Thrombosis and Thromboprophylaxis Steering

More information

PRIMARY CARE PRACTICE GUIDELINES

PRIMARY CARE PRACTICE GUIDELINES 1 of 12 1. OUTCOME To provide direction regarding the standard processes for managing WRHA Primary Care Clinic clients who receive anticoagulation therapy with warfarin. To improve safety and reduce risk.

More information

Expanding Your Pharmacist Team

Expanding Your Pharmacist Team CALIFORNIA QUALITY COLLABORATIVE CHANGE PACKAGE Expanding Your Pharmacist Team Improving Medication Adherence and Beyond August 2017 TABLE OF CONTENTS Introduction and Purpose 1 The CQC Approach to Addressing

More information

Low Molecular Weight Heparins

Low Molecular Weight Heparins ril 2014 Low Molecular Weight Heparins FINAL CONSOLIDATED COMPREHENSIVE RESEARCH PLAN September 2015 FINALCOMPREHENSIVE RESEARCH PLAN 2 A. Introduction The objective of the drug class review on LMWH is

More information

Lewisham Integrated Medicines Optimisation Service

Lewisham Integrated Medicines Optimisation Service Lewisham Integrated Medicines Optimisation Service By Kath Howes (CCG) & Kay Fahy (University Hospital Lewisham) Katherine.howes@nhs.net LIMOS: 02030493228 Seen this before??- Hoarding & Wastage The Story

More information

Quality Standards for Enhanced Primary Care Services. Version 1.2

Quality Standards for Enhanced Primary Care Services. Version 1.2 Quality Standards for Enhanced Primary Care Services Version 1.2 September 2014 8831 September 2014 West Midlands Quality Review Service These Quality Standards may be reproduced and used freely by NHS

More information

Improvement Activities Data Validation Criteria

Improvement Activities Data Validation Criteria Activity ID Subcategory Activity Name Activity Description Activity Validation Suggested Documentation (inclusive of dates during the selected continuous 90-day or year Name Weighting long reporting period)

More information

Schedule C1. Community Pharmacy Anti-Coagulation Management Services

Schedule C1. Community Pharmacy Anti-Coagulation Management Services Schedule C1 Community Pharmacy Anti-Coagulation Management Services 1. Definition This service specification relates to the anticoagulation management of Service Users on warfarin by an accredited community

More information

Provide Safe and Effective Medicines Management in Primary Care

Provide Safe and Effective Medicines Management in Primary Care Primary Drivers Secondary Drivers Aim Safe and reliable prescribing, monitoring and administration of high risk medications that require systematic monitoring Implement systems for reliable prescribing

More information

Dr Vincent Kirchner, MEDICAL DIRECTOR. Date Version Summary of amendments Oct New Procedure

Dr Vincent Kirchner, MEDICAL DIRECTOR. Date Version Summary of amendments Oct New Procedure OLANZAPINE DEPOT PROCEDURE OCTOBER 2017 Policy title Policy reference Policy category Relevant to Date published Implementatio n date Date last reviewed Next review date Policy lead Contact details Accountable

More information

Standard operating procedures: Health facility malaria committees

Standard operating procedures: Health facility malaria committees The MalariaCare Toolkit Tools for maintaining high-quality malaria case management services Standard operating procedures: Health facility malaria committees Download all the MalariaCare Tools from: www.malariacare.org/resources/toolkit

More information

Patients Own Medications Policy

Patients Own Medications Policy Department of Health and Human Services SYSTEM PURCHASING AND PERFORMANCE - MEDICATION STRATEGY AND REFORM SDMS Id Number: Patients Own Medications Policy Effective From: June 2014 Replaces Doc. No: Custodian

More information

OSCE demo Oral Structured Clinical Examination

OSCE demo Oral Structured Clinical Examination OSCE demo Oral Structured Clinical Examination Patient interview. ü Aim: Identify incorrect medications in medication list Physician discussion. ü Aim: Implement correct medication list Tommy Eriksson

More information

Licensed Pharmacy Technicians Scope of Practice

Licensed Pharmacy Technicians Scope of Practice Licensed s Scope of Practice Adapted from: Request for Regulation of s Approved by Council April 24, 2015 DEFINITIONS In this policy: Act means The Pharmacy and Pharmacy Disciplines Act means an unregulated

More information

POLICY AND PROCEDURE DEPARTMENT: Pharmacy Operations

POLICY AND PROCEDURE DEPARTMENT: Pharmacy Operations PAGE: 1 of 6 SCOPE: Centene Corporate Pharmacy Department, Centene Corporate Pharmacy and Therapeutics Committee, Health Plan Pharmacy Departments, Health Plan Pharmacy and Therapeutics Committees, and

More information

Performance Measurement of a Pharmacist-Directed Anticoagulation Management Service

Performance Measurement of a Pharmacist-Directed Anticoagulation Management Service Hospital Pharmacy Volume 36, Number 11, pp 1164 1169 2001 Facts and Comparisons PEER-REVIEWED ARTICLE Performance Measurement of a Pharmacist-Directed Anticoagulation Management Service Jon C. Schommer,

More information

Overview of e-portfolio Learning Activities for Part III Community Pharmacy Placements

Overview of e-portfolio Learning Activities for Part III Community Pharmacy Placements Overview of e-portfolio Learning Activities for Part III Community Pharmacy Placements Placement Module 2 & 3 The following sections must be completed for Placement. Pre-placement Preparation My Glossary

More information

This document provides information on conducting the Perindopril New To Therapy Program using GuildCare software.

This document provides information on conducting the Perindopril New To Therapy Program using GuildCare software. Perindopril New To Therapy Program PROTOCOL This document provides information on conducting the Perindopril New To Therapy Program using GuildCare software. April 2015 Table of Contents Executive Summary...

More information

University of Mississippi Medical Center University of Mississippi Health Care. Pharmacy and Therapeutics Committee Medication Use Evaluation

University of Mississippi Medical Center University of Mississippi Health Care. Pharmacy and Therapeutics Committee Medication Use Evaluation University of Mississippi Medical Center University of Mississippi Health Care Pharmacy and Therapeutics Committee Medication Use Evaluation TJC Standards for Medication Management March 2012 Purpose The

More information

PHARMACY SERVICES/MEDICATION USE

PHARMACY SERVICES/MEDICATION USE 25.01. 10 Drug Reactions & Administration Errors & Incompatibilities. Drug administration errors, adverse drug reactions and incompatibilities must be immediately reported to the attending physician and

More information

Constant Pursuit of Medication Safety. Geraldine Koh Chief Pharmacist

Constant Pursuit of Medication Safety. Geraldine Koh Chief Pharmacist Constant Pursuit of Medication Safety Geraldine Koh Chief Pharmacist 1 Alexandra Hospital 400 beds Multi discipline except Paeds & ObGyn Restructured in Oct 2000 Transformation Creating A Safety Culture

More information

The Joint Commission Medication Management Update for 2010

The Joint Commission Medication Management Update for 2010 Learning Objectives The Joint Commission Medication Management Update for 2010 U.S. Army Medical Command Fort Sam Houston, TX Describe most recent changes in The Joint Commission (TJC) Accreditation Program

More information

Fundamentals of Self-Limiting Conditions Prescribing for Manitoba Pharmacists. Ronald F. Guse Registrar College of Pharmacists of Manitoba (CPhM)

Fundamentals of Self-Limiting Conditions Prescribing for Manitoba Pharmacists. Ronald F. Guse Registrar College of Pharmacists of Manitoba (CPhM) Fundamentals of Self-Limiting Conditions Prescribing for Manitoba Pharmacists Ronald F. Guse Registrar College of Pharmacists of Manitoba (CPhM) 1 Learning Objectives Upon successful completion of this

More information

PAGE NO 1. INTRODUCTION 3 2 WARFARIN INITIATION GUIDELINES WARFARIN FLOWCHART. 5 4 WDHB WARFARIN PATHWAY 6 5 WDHB GP REFERRAL FORM 7

PAGE NO 1. INTRODUCTION 3 2 WARFARIN INITIATION GUIDELINES WARFARIN FLOWCHART. 5 4 WDHB WARFARIN PATHWAY 6 5 WDHB GP REFERRAL FORM 7 Guidelines for Primary Care Com mmunity-based Clinicians September 2011 IINDEX PAGE NO 1. INTRODUCTION 3 2 WARFARIN INITIATION GUIDELINES... 4 3. WARFARIN FLOWCHART. 5 4 WDHB WARFARIN PATHWAY 6 5 WDHB

More information

Introduction of EPMA in paediatric practice in UK:

Introduction of EPMA in paediatric practice in UK: Introduction of EPMA in paediatric practice in UK: REALISING THE CLINICAL BENEFITS AND ENGAGING CLINICAL STAFF Stephen Marks Consultant Paediatric Nephrologist and EPMA lead Great Ormond Street Hospital

More information

South Staffordshire and Shropshire Healthcare NHS Foundation Trust

South Staffordshire and Shropshire Healthcare NHS Foundation Trust South Staffordshire and Shropshire Healthcare NHS Foundation Trust Document Version Control Document Type and Title: Authorised Document Folder: Policy for Medicines Reconciliation on Admission and on

More information

Community Clinics Policy and Procedure Manual C - 9 WARFARIN ADJUSTMENT PROTOCOL SUBJECT: WARFARIN ADJUSTMENT PROTOCOL

Community Clinics Policy and Procedure Manual C - 9 WARFARIN ADJUSTMENT PROTOCOL SUBJECT: WARFARIN ADJUSTMENT PROTOCOL Community Clinics Policy and Procedure Manual C - 9 SUBJECT: WARFARIN ADJUSTMENT PROTOCOL SUBJECT: WARFARIN ADJUSTMENT PROTOCOL APPROVED BY: VP Acute & Long Term Care & COO (South) EFFECTIVE DATE: 2007

More information

Medication Management and Use. Anadolu Medical Center. August, Departman Tarih

Medication Management and Use. Anadolu Medical Center. August, Departman Tarih Medication Management and Use Anadolu Medical Center August, 2014 Departman Tarih Medication Management and Use standards (MMU) Organization and Management 1. Medication use in the hospital is organized

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Single Technology Appraisal (STA)

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Single Technology Appraisal (STA) Thank you for agreeing to give us a statement on your organisation s view of the technology and the way it should be used in the NHS. Healthcare professionals can provide a unique perspective on the technology

More information

NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST MEDICINES CODE OF PRACTICE MEDICINES MANAGEMENT WHEN PATIENTS ARE DISCHARGED FROM HOSPITAL

NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST MEDICINES CODE OF PRACTICE MEDICINES MANAGEMENT WHEN PATIENTS ARE DISCHARGED FROM HOSPITAL NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST MEDICINES CODE OF PRACTICE MEDICINES MANAGEMENT WHEN PATIENTS ARE DISCHARGED FROM HOSPITAL Reference CL/MM/024 Date approved 13 Approving Body Directors Group

More information

POLICY AND PROCEDURE DEPARTMENT: Pharmacy Operations

POLICY AND PROCEDURE DEPARTMENT: Pharmacy Operations PAGE: 1 of 5 SCOPE: Centene Corporate Pharmacy Solutions, Centene Corporate Pharmacy and Therapeutics Committee, Health Plan Pharmacy Departments, Health Plan Pharmacy and Therapeutics Committees, Pharmacy

More information

Medicine Management Policy

Medicine Management Policy INDEX Prescribing Page 2 Dispensing Page 3 Safe Administration Page 4 Problems & Errors Page 5 Self Administration Page 7 Safe Storage Page 8 Controlled Drugs Best Practice Procedure Page 9 Controlled

More information

CRAIG HOSPITAL POLICY/PROCEDURE

CRAIG HOSPITAL POLICY/PROCEDURE CRAIG HOSPITAL POLICY/PROCEDURE Approved: P&T, MEC, NPC, P&P 03/09 Effective Date: 02/95 P&T, MEC, P&P 08/09; P&P 08/10; P&T, MEC 10/10, P&T, P&P 12/10 ; MEC 01/11; P&T, MEC 02/11, 04/11 ; P&T, P&P 12/11

More information

SELF - ADMINISTRATION OF MEDICINES AND ADMINISTRATION OF MEDICINES SUPPORTED BY FAMILY/INFORMAL CARERS OF PATIENTS IN COMMUNITY NURSING

SELF - ADMINISTRATION OF MEDICINES AND ADMINISTRATION OF MEDICINES SUPPORTED BY FAMILY/INFORMAL CARERS OF PATIENTS IN COMMUNITY NURSING CLINICAL PROTOCOL SELF - ADMINISTRATION OF MEDICINES AND ADMINISTRATION OF MEDICINES SUPPORTED BY FAMILY/INFORMAL CARERS OF PATIENTS IN COMMUNITY NURSING RATIONALE Medication errors can cause unnecessary

More information

NYSPFP ADE Optimizing Anticoagulation Care Series:

NYSPFP ADE Optimizing Anticoagulation Care Series: NYSPFP ADE Optimizing Anticoagulation Care Series: Understanding Risks, Benefits, and Treatment Indications April 2018 1 A partnership of the Healthcare Association of New York State and the Greater New

More information

Accreditation Program: Long Term Care

Accreditation Program: Long Term Care ccreditation Program: Long Term are National Patient Safety Goals indicates scoring category ; indicates scoring category ; indicates situational decision rules apply; indicates 2009 The Joint ommission

More information